Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration-Reference-Cited by-同舟云学术

Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration

Published:2023 Issue:3 Volume:63 Page:187-192
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Oyama Takashi¹,Yasunaga Megumi¹,Jona Masahiro²,Nishikawa Masako²,Yatomi Yutaka²,Honda Akira¹,Maki Hiroaki¹,Morita Ken¹,Masamoto Yosuke¹,Kurokawa Mineo¹

Affiliation:

1. Department of Hematology and Oncology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan,

2. Department of Clinical Laboratory, the University of Tokyo Hospital, Tokyo, Japan,

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/63/3/63_23023/_pdf

Reference19 articles.

1. 1 Hallek M, Cheson BD, Catovsky D et al. International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111: 5446-5456.

2. 2 Zent CS, Ding W, Schwager SM et al. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol. 2008; 141: 615-621.

3. 3 Rogers KA, Woyach JA. Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Semin Oncol. 2016; 43: 300-310.

4. 4 Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986; 39: 713-716.

5. 5 Tsang M, Parikh SA. A concise review of autoimmune cytopenias in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2017; 12: 29-38.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-05-04